Know Cancer

or
forgot password

Effective Communication for Preventing and Responding to Oncology Adverse Events


N/A
21 Years
80 Years
Open (Enrolling)
Both
Cancer

Thank you

Trial Information

Effective Communication for Preventing and Responding to Oncology Adverse Events


Inclusion Criteria:



- Cancer survivors

- 21 to 80 years of age

- Able to communicate in English

- have adequate hearing

- no cognitive impairments

Exclusion Criteria:

-Any non-melanoma skin cancer, Breast cancer in situ, Cervical intraepithelial neoplasia
(CIN): types I, II, III, Stage I colon cancer, Stage IV cancer, Recurrent cancer or second
primary

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Outcome Measure:

Calculate differences in satisfaction with cancer care communication, using a summary score from patient surveys, between intervention and control groups.

Outcome Time Frame:

8 months

Safety Issue:

No

Principal Investigator

Kathleen M Mazor, EdD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Massachusetts, Worcester

Authority:

United States: Institutional Review Board

Study ID:

1184

NCT ID:

NCT01871948

Start Date:

October 2008

Completion Date:

February 2014

Related Keywords:

  • Cancer

Name

Location

Kaiser Permanente GeorgiaAtlanta, Georgia  30300
Group HealthSeattle, Washington  98124